Crohn’s Disease Treatment Market Is Expected to Reach US$ 10 Billion at a 4.3% CAGR By 2025 – Coherent Market Insights
SEATTLE, March 17, 2021, (PHARMIWEB) —
Crohn’s Disease Treatment Market – Insights
Crohn’s disease is a chronic inflammatory bowel disease that affects the lining of the digestive tract. Stress, diet, malfunctioning of the immune system, and heredity are some of the factors that cause Crohn’s disease. The disease is confined to the colon of the large intestine and ileum of the small intestine and can lead to life-threatening complications in some cases. Although, the condition can occur at any age, it is likely to develop at a young age. Crohn’s disease may comprise of one or more factors that include, bowel obstruction, fistulas, ulcers, anal fissures, colon cancer, and other health issues. There are no specific and dedicated tests to diagnose the Crohn’s disease and is confirmed after ruling out the possible symptoms and signs of the disease.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1237
Although there is no specific cure for the condition, various therapies can help reduce its signs and symptoms and result in long-term remission. Prescription of anti-inflammatory drugs, immune system suppressers, antibiotics, and other medication that help to control inflammation may lead to long-term prognosis.
The global Crohn’s disease treatment market was valued at US$ 9.4 billion in 2017 and is expected to witness a CAGR of 4.3% over the forecast period (2017–2025).
Figure 1. Global Crohn’s Disease Treatment Market Value (US$ Mn), by Region, 2018
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://bit.ly/3bSU0oN
Crohn’s Disease Treatment Market: Drivers
High prevalence of gastrointestinal diseases and Crohn’s disease is expected to boost growth of the global Crohn’s disease treatment market. For instance, according to the Lancet 2016, the global burden of inflammatory bowel disease contributes to 0.3% of the total disease burden of the globe. Moreover, according to the National Institute of Health, Crohn’s disease and ulcerative colitis affected 1.5 million people in North America and 2.5 million people in the Europe in 2015.
Increasing R&D of novel therapies is also expected to propel growth of the market. For instance, researchers from University of Washington Medicine at the Crohn’s & Colitis Congress held in January 2018 presented a study that developed an antibiotic that demonstrated four fold better response on the inflammation of intestine among patients suffering with Crohn’s disease compared to existing therapies available in the market.
Major government bodies are focused on improving quality of life of patients suffering from Crohn’s disease, which is expected to boost growth of the market. For instance, The European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA) is an umbrella organization that represents 34 national patient associations and works for improving the life of patients suffering with irritable bowel syndrome in various countries across Europe. Moreover, The Center for Drug Evaluation and U.S. FDA released a new document named New Drug Therapy Approvals in 2017 that included fast-track drug and biosimilar approval clauses for Crohn’s disease and inflammatory bowel disease.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/crohns-disease-treatment-market-to-surpass-us-10-billion-by-2025-890
Crohn’s Disease Treatment Market: Restraints
Major factors hampering the market growth include, low awareness about the available treatment options for Crohn’s disease in middle- and low-income economies and patient expiry of biologics.
Crohn’s Disease Treatment Market: Regional Analysis
On the basis of region, the global Crohn’s disease treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to account for the largest market share over the forecast period, owing to R&D of novel biosimilars and drugs for the treatment of Crohn’s disease. For instance, in August 2016, the U.S. Food and Drug Administration (FDA) approved two biosimilars Erelzi and Amjevita, manufactured by Amgen for the treatment of inflammatory bowel disease. Moreover, increasing prevalence of Crohn’s disease is also expected to contribute to market growth in North America. For instance, according to the Canadian Society of Intestinal Research 2011, Canada had the highest incidence of Crohn’s disease reported across the world with over 13.4 new cases per 100,000 of population.
Increasing R&D of biosimilars for the treatment of Crohn’s disease is expected to boost growth of the market in Asia Pacific. For instance, in April 2016, the U.S. Food and Drug Administration (FDA) approved Inflectra developed by Celtrion, Inc., which is a biosimilar to Remicade patented by Janssen Biotech, Inc. for adult and pediatric patients suffering with Crohn’s disease and have inadequate response to conventional therapies.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1237
Crohn’s Disease Treatment Market: Competitive Landscape
Key players in the market are focused on product development and launch to expand their product portfolio. For instance, in September 2016, Janssen Biotech, Inc, received the U.S. FDA approval for STELARA for the treatment of moderate to severe Crohn’s disease that have failed responding to the immunomodulators and corticosteroid treatments earlier.
Major players operating the global Crohn’s disease treatment market include Bayer AG, Bristol-Myers Squibb, Pfizer, Inc., AbbVie Inc., Janssen Biotech, Inc., Allergan Inc., GlaxoSmithKline plc, Novartis International AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Company, Sanofi S.A., and Takeda Pharmaceutical Company Limited.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Market Trends
- PORTER’s Five Forces Analysis
- Epidemiology
- Market Dynamics
- Global Crohn’s Disease Treatment Market, By Drug Type, 2018-2026, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Antibiotics
- Amino Salicylates
- Corticosteroids
- Immunomodulators
- Others
- Introduction
- Global Crohn’s Disease Treatment Market, By Distribution Channel, 2018-2026, (US$ Million)
- Introduction
- Market Share Analysis, 2017 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
- Introduction
- Global Crohn’s Disease Treatment Market, By Region, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2017 and 2026 (%)
- Y-o-Y Growth Analysis, Region, 2017 – 2026
- North America
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
- Market Size and Forecast, By Country, 2016-2026, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Section
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
